Biopharmx Corp (BPMX) Sees Significant Drop in Short Interest

Biopharmx Corp (NYSE:BPMX) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totalling 4,790,336 shares, a decline of 6.7% from the July 14th total of 5,135,164 shares. Approximately 8.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 697,859 shares, the days-to-cover ratio is presently 6.9 days.

Separately, ValuEngine upgraded Biopharmx Corp from a “strong sell” rating to a “sell” rating in a research note on Wednesday, May 24th.

Shares of Biopharmx Corp (NYSE BPMX) opened at 0.298 on Thursday. The stock’s market capitalization is $22.09 million. Biopharmx Corp has a 1-year low of $0.19 and a 1-year high of $1.22. The company has a 50 day moving average price of $0.44 and a 200-day moving average price of $0.52.

COPYRIGHT VIOLATION WARNING: This article was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/2796408/biopharmx-corp-bpmx-sees-significant-drop-in-short-interest.html.

About Biopharmx Corp

BioPharmX Corporation is a specialty pharmaceutical company. The Company is focused on utilizing its drug delivery technologies to develop and commercialize prescription and over-the-counter (OTC) products that address markets in women’s health and dermatology. Its portfolio of product candidates includes two clinical stage product candidates: BPX01, which is a topical antibiotic for the treatment of acne based on a formulation of minocycline, and BPX03, which is a molecular iodine (I2) tablet for the treatment of benign breast pain associated with fibrocystic breast condition (FBC) and cyclic mastalgia.

Receive News & Ratings for Biopharmx Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.